Sign in
← Database
Nootropic (Racetam)

Aniracetam

Shop · Omnichems ↗Buy · Disguised Alpha ↗
Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

A fat-soluble racetam nootropic studied for cognition and mood, marketed as a drug in some countries but unapproved in the US.

How it works

Aniracetam belongs to the racetam family, a group of compounds derived from a pyrrolidinone ring that are studied for effects on memory, attention, and mood. Unlike the original racetam, piracetam, aniracetam is fat-soluble, which influences how it moves through the body and brain. It has been investigated for age-related cognitive decline and has a long history of off-label use as a nootropic.

Mechanistically, aniracetam is thought to act on the brain's main excitatory signaling system, glutamate, by modulating a class of receptors called AMPA receptors. By slowing how quickly these receptors deactivate, it may enhance the signaling involved in learning and memory. It has also been reported to influence other neurotransmitter systems, which some researchers connect to its possible mood and anxiety-related effects.

It is important to be clear-eyed about the evidence. Aniracetam has been approved and prescribed in some countries, but the clinical trial literature is older and of variable quality, and results are not consistent. In the United States it is not an approved drug and is sold as a research chemical or supplement, so purity and safety oversight are limited.

Mechanism · Detailed Analysis
Molecular targetAniracetam is described as a positive allosteric modulator of AMPA-type glutamate receptors, slowing their desensitization and deactivation. This 'ampakine-like' action is the most cited basis for its proposed cognitive effects.
Signaling & downstream effectsBy enhancing AMPA-mediated excitatory transmission, it is thought to facilitate synaptic plasticity relevant to learning and memory. It has additionally been reported to influence cholinergic, dopaminergic, and serotonergic signaling, mechanisms sometimes linked to its purported mood and anxiolytic effects.
PharmacokineticsAniracetam is lipophilic, absorbed orally, and undergoes extensive first-pass metabolism to metabolites such as anisic-acid derivatives; the parent compound has a short half-life. Brain entry is favored by its fat solubility, though human exposure data are limited.
CaveatsClinical evidence is older and inconsistent in quality. It is unapproved in the US and sold without pharmaceutical oversight, so purity, dosing accuracy, and long-term safety are not assured.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.